Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost
Robert D Fechtner1, Paul Harasymowycz2, Donald R Nixon3, Steven D Vold4, Fiaz Zaman5, Julia M Williams6, David A Hollander61Glaucoma Division, University of Medicine and Dentistry New Jersey, Newark, NJ, USA; 2University of Montreal, Montreal, QC, Canada; 3Royal Victoria Hospital, Barrie, ON, Canada...
Main Authors: | Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-07-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/twelve-week-randomized-multicenter-study-comparing-a-fixed-combination-a7830 |
Similar Items
-
Comparison of brimonidine-timolol and dorzolamide-timolol in the management of intraocular pressure increase after phacoemulsification
by: Adem Turk, et al.
Published: (2015-10-01) -
A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure
by: Curt Hartleben, et al.
Published: (2017-01-01) -
Comparison of the effects of antiglaucomatous fixed combinations and patients compliance: Dorzolamide-timolol maleate and latanoprost-timolol maleate
by: Kubilay Çetinkaya, et al.
Published: (2012-03-01) -
Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
by: Masahiro Fuwa, et al.
Published: (2016-01-01) -
Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
by: Kenji Inoue, et al.
Published: (2014-01-01)